FOXO4-DRI enters senescent cells and competitively binds to p53 through its modified peptide sequence, displacing endogenous FOXO4 and freeing p53 to activate cell death pathways including BAX and PUMA
For weight management, NICE (TA875) recommends semaglutide 2.4 mg (Wegovy) for adults with a BMI of 35 kg/m or greater (or 32.5 kg/m or greater for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) who have at least one weight-related comorbidity
Tirzepatide titration: 2.5mg to 15mg Tirzepatide uses a six-step titration over approximately 20-24 weeks: Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Weeks 17-20: 12.5mg weekly Week 21 onward: 15mg weekly (maximum dose) Not everyone reaches 15mg
Whether Kaiser will participate is unknown
CD8 regulatory T cells are critical in prevention of autoimmune-mediated diabetes
It is not for human or veterinary use, and not for clinical or diagnostic application